Main Types of Fibroblast Growth Factors: Biological Functions and Significance
https://doi.org/10.18499/2225-7357-2025-14-3-77-83
Abstract
An analytical review of domestic and foreign publications from the last ten years on the structure, receptor interactions, and physiological role of the main types of fibroblast growth factors (FGFs) in humans has been conducted. FGFs are involved in angiogenesis, wound healing, and embryogenesis. In humans, 23 members of the fibroblast growth factor family have been identified. FGF representatives can be broadly divided into three families based on their functional differences. The first family comprises FGF1–FGF10. The second family unites the homologous fibroblast growth factors, FGF11–FGF14. The third family includes FGF16– FGF23. Within this third family, a distinct group of factors – FGF19, FGF21, and FGF23 – can be identified, which, unlike other family members, exert systemic effects. The structure, receptor interactions, and physiological role of the main types of FGFs in humans are described. Based on the compiled data, a functional classification of the FGF family is proposed: canonical FGFs 1–10, homologous FGFs 11–14, and endocrine FGFs 19, 21, and 23. The article highlights their roles in angiogenesis, embryogenesis, connective tissue regeneration, neurogenesis, and metabolic regulation. A detailed description of FGF21 as a promising biomarker and therapeutic target for metabolic syndrome and type 2 diabetes is provided. The systematization of knowledge on FGFs underscores their significance in both normal physiology and pathology, and lays the groundwork for the development of novel pharmacological strategies.
About the Authors
V. L. Zagrebin
Volgograd State Medical University
Russian Federation
Russian Federation
Valerii L. Zagrebin - Cand. Sci. (Med.), Associate Professor, head of the Department of Histology, Cytology, Embryology, Volgograd State Medical University.
Pavshikh Boitsov pl., 1, Volgograd, 400131
I. V. Derevyanko
Volgograd State Medical University
Russian Federation
Russian Federation
Igor' V. Derevyanko - Cand. Sci. (Med.), Associate Professor at the Department of Histology, Cytology, Embryology, Volgograd State Medical University.
Pavshikh Boitsov pl., 1, Volgograd, 400131
G. A. Sim
Volgograd State Medical University
Russian Federation
Russian Federation
Georgii A. Sim – student, Volgograd State Medical University.
Pavshikh Boitsov pl., 1, Volgograd, 400131
S. G. Plachinta
Volgograd State Medical University
Russian Federation
Russian Federation
Sergei G. Plachinta - Senior Laboratory Assistant at the Department of Histology, Cytology, Embryology, Volgograd State Medical University.
Pavshikh Boitsov pl., 1, Volgograd, 400131
References
1. Alieva AM, Teplova NV, Reznik EV, Baikova IE, Khadzhieva NKh, Voronkova KV. et. al. Faktor rosta fibroblastov 21-novyi instrument v mnogokomponentnoi otsenke serdechno-sosudistykh zabolevanii. Rossiiskii meditsinskii zhurnal. 2022;28(1):75-88. doi: 10.17816/medjrf108900. (In Russ.).
2. Bazhan NM. Uglevodno-zhirovoi obmen: vliyanie faktora rosta fibroblastov 21 (FGF21) v zavisimosti ot pola i tipa ozhireniya. Integrativnaya fiziologiya: Vserossiiskaya konferentsiya s mezhdunarodnym uchastiem. Tezisy dokladov, Sankt-Peterburg, 0608 dekabrya 2023 goda. Sankt-Peterburg : Institut fiziologii im. I.P. Pavlova RAN; 2023. 8. (In Russ.).
3. Balmukhanova AM, Kanatbaeva AB, Kabulbaev KA, Karasaev MI, Batyrbaeva DZh. Znachenie faktora rosta fibroblastov 23 (FGF-23) v organizme cheloveka. Meditsina (Almaty). 2020;7-8(217-218):37-43. (In Russ.). doi: 10.31082/1728-452X-2020-217-218-7-8-37-43.
4. Belyakova KL, Sheveleva AR. The effect of nk cells on angiogenesis in the presence of vascular endothelial growth factor and basic fibroblast growth factor. Journal of Obstetrics and Women's Diseases. 2017; 66(S): 99-100. (In Russ.).
5. Gronskaya S.A., Rusyaeva N.V., Belaya Zh.E., Mel'nichenko G.A. Neklascicheskie gormony iz semeistva faktorov rosta fibroblastov. Problemy endokrinologii. 2024;70(5):23-33. (In Russ.). doi: 10.14341/probl13441.
6. Dzgoeva FU, Sopoev MYu, Bestaeva TL, Khamitsaeva OV, Gigolaev DA. Faktor rosta fibroblastov-23 i serdechnososudistye oslozhneniya pri khronicheskoi bolezni pochek. Nefrologiya. 2015;19(5):49-56. (In Russ.).
7. Ivoilova TV, Gladkova AE. Rol' faktora rosta fibroblastov i ego retseptorov v patogeneze onkologicheskikh zabolevanii. X mezhdunarodnyi molodezhnyi nauchnyi meditsinskii forum "Belye tsvety", posvyashchennyi 150-letiyu S.S. Zimnitskogo : Sbornik tezisov, Kazan', 12-14 aprelya 2023 goda. Kazan' : Kazanskii gosudarstvennyi meditsinskii universitet, 2023. 499-500. (In Russ.).
8. Indeikina LKh, Sabel'nikova EA, Varvanina GG. Sil'vestrova SYu., Smirnova AV, Krums LM., et al. Znachenie faktora rosta fibroblastov 19 v patogeneze khologennoi diarei u patsientov, perenesshikh kholetsistektomiyu. Terapevticheskii arkhiv. 2O2i;93(2):i74-i78. (In Russ.). doi: 10.26442/00403660.2021.02.200621.
9. Kopylov V.A., Safronov A.A. Experimental development of new drug containing fibroblast growth factor for the treatment of open fracture. The department of traumatology and orthopedics. 2016;1(17): 5-9. (In Russ.).
10. Gronskaya SA, Rusyaeva NV, Belaya ZhE, Mel'nichenko GA. Neklasicheskie gormony iz semeistva faktorov rosta fibroblastov. Problemy Endokrinologii. 2024;70(5):23-33. (In Russ.). doi: 10.14341/probl13441.
11. Samoilova YuG, Denisov NS, Kuz'menko DI, Kudlai DA, Oleinik OA, Podchinenova DV, et al. Rol' faktorov rosta fibroblastov 19, 21 i belka Klotho v razvitii insulinorezistentnosti i ozhireniya u detei. Pediatriya im. G.N. Speranskogo. 2022;101(2):86-91. (In Russ.). doi: 10.24110/0031-403X-2022-101-2-86-91.
12. Selina PI. Faktor rosta soedinitel'noi tkani i belok aktivatsii fibroblastov kak prognosticheskie markery onkogeneza. Vestnik Voennogo innovatsionnogo tekhnopolisa "Era". 2023;4(3):233-239. (In Russ.). doi: 10.56304/S2782375X23030166.
13. Ten EA, Babkina IV, Kuznetsov IN, Bondarev AV, Schupak MYu, Soloviev YuN, Aliev MD. Fibroblast growth factor type 1 and 2 in the serum at a primary malignant bone tumor. Problems of biological, medical and pharmaceutical chemistry. 2016;19(8): 27-31. (In Russ.).
14. Shalygina AA, Turgunova LG, Laryushina EM, Sher'yazdanova DN Otsenka urovnya faktora rosta fibroblastov-21 u lits s metabolicheskim sindromom. Kardiovaskulyarnaya terapiya i profilaktika. 2019;18(S1):164. (In Russ.).
15. Shurygina IA, Shurygin MG, Ayushinova NI, Kanya OV. Fibroblasty i ikh rol' v razvitii soedinitel'noi tkani. Sibirskii meditsinskii zhurnal. 2012;(3):8-12. (In Russ.).
16. Shchava SP. Vascular growth factors and neoangiogenesis in hypoxia and ischemia. Far Eastern medical journal. 2007;1: 127-131. (In Russ.).
17. Antonova L, Kutikhin A, Sevostianova V, Velikanova E, Matveeva V, Glushkova T, et al. bFGF and SDF-ia Improve In Vivo Performance of VEGF-Incorporating Small-Diameter Vascular Grafts. Pharmaceuticals (Basel). 2021 Mar 28;14(4):302. doi: 10.3390/ph14040302.
18. Armelin HA. Pituitary extracts and steroid hormones in the control of 3T3 cell growth. Proc Natl Acad Sci U S A. 1973 Sep;70(9):2702-6. doi: 10.1073/pnas.70.9.2702.
19. Bobbert T, Schwarz F, Fischer-Rosinsky A, Pfeiffer AF, Möhlig M, Mai K, Spranger J. Fibroblast growth factor 21 predicts the metabolic syndrome and type 2 diabetes in Caucasians. Diabetes Care. 2013 Jan;36(1):145-9. doi: 10.2337/dc12-0703.
20. Chen C, Cheung BM, Tso AW, Wang Y, Law LS, Ong KL, et al. High plasma level of fibroblast growth factor 21 is an Independent predictor of type 2 diabetes: a 5.4-year population-based prospective study in Chinese subjects. Diabetes Care. 2011 Sep;34(9):2113-5. doi: 10.2337/dc11-0294.
21. Choi JR, Kim JY, Park IH, Huh JH, Kim KW, Cha SK, et al. Serum Fibroblast Growth Factor 21 and New-Onset Metabolic Syndrome: KoGES-ARIRANG Study. Yonsei Med J. 2018 Mar;59(2):287-293. doi: 10.3349/ymj.2018.59.2.287.
22. Degirolamo C, Sabbà C, Moschetta A. Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23. Nat Rev Drug Discov. 2016 Jan;15(1):51-69. doi: 10.1038/nrd.2015.9.
23. Flavell SJ, Hou TZ, Lax S, Filer AD, Salmon M, Buckley CD. Fibroblasts as novel therapeutic targets in chronic inflammation. Br J Pharmacol. 2008 Mar;153 Suppl 1(Suppl 1):S241-6. doi: 10.1038/sj.bjp.0707487.
24. Hartlapp I, Abe R, Saeed RW, Peng T, Voelter W, Bucala R, Metz CN. Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo. FASEB J. 2001 Oct;15(12):2215-24. doi: 10.1096/fj.01-0049com.
25. Keeley EC, Mehrad B, Strieter RM. Fibrocytes: bringing new insights into mechanisms of inflammation and fibrosis. Int J Biochem Cell Biol. 2010 Apr;42(4):535-42.
26. Murugaiyan K, Amirthalingam S, Hwang NS, Jayakumar R. Role of FGF-18 in Bone Regeneration. J Funct Biomater. 2023 Jan 8;14(1):36. doi: 10.3390/jfb14010036.
27. Soliyev AU. Qari va keksalarda arterial gipertoniya tarqalishi va xavf omillarining uchrashi. Biomeditsina va amaliyot jurnali. 2020:435-441.
28. Staiger H, Keuper M, Berti L, Hrabe de Angelis M, Häring HU. Fibroblast Growth Factor 21-Metabolic Role in Mice and Men. Endocr Rev. 2017 Oct 1;38(5):468-488.
29. Zechel S, Werner S, Unsicker K, von Bohlen und Halbach O. Expression and functions of fibroblast growth factor 2 (FGF-2) in hippocampal formation. Neuroscientist. 2010 Aug;16(4):357-73. doi: 10.1177/1073858410371513
Review
For citations:
Zagrebin V.L., Derevyanko I.V., Sim G.A., Plachinta S.G. Main Types of Fibroblast Growth Factors: Biological Functions and Significance. Journal of Anatomy and Histopathology. 2025;14(3):77-83. (In Russ.) https://doi.org/10.18499/2225-7357-2025-14-3-77-83
Views:
79
Email this article 